ELAN MEXC RealStocks
Own real ELAN shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 08:04:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Elanco Animal Health Incorporated (ELAN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $26.69, with a market capitalization of $12.92B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $19.40 to $27.98. This page covers its latest market performance, valuation, price trends and company information.
$12.92B | |
$25.31 | |
$27.00 | |
$25.31 | |
$25.85 | |
4.83M | |
5.28M | |
-- | |
$27.98 | |
$19.40 | |
-- | |
2026-09-30 |
Elanco Animal Health Incorporated (ELAN) last closed at $26.69 as of 2026-11-19 00:31:00, up 3.29% ($0.85) from the previous close of $25.85.
During the latest regular trading session, ELAN traded between $25.31 and $27.00, with a volume of 4.83M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Elanco Animal Health Incorporated (ELAN) moved from $26.76 to $26.69, representing a decline of 0.25% ($0.07).
The stock traded between $25.31 and $27.17 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.
The average daily volume was 4.62 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 85.0%
ELAN is currently trading at $26.69, placing it 85.0% of the way from its 52-week low of $19.40 to its 52-week high of $27.98. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 9,900 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Elanco Animal Health Incorporated (ELAN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ELAN, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ELAN shares and USD.
ELAN Shares to USD
1.00 ELAN shares = 26.693 USD
Calculations are estimates based on the latest available price and are for reference only.